Home » Newsletters » BioWorld Science

BioWorld Science

July 23, 2001

View Archived Issues

AlphaGene and Lahey Clinic form strategic alliance for prostate cancer research

Celltech and NeoGenesis form research collaboration

AtheroGenics acquires new drug discovery technology

FDA approves study of vagus nerve stimulation for migraine

Clinical study of VNS for rapid cycling bipolar disorder cleared by U.S. authorities

Once-daily dosing of RWJ-270201 appears feasible according to pharmacodynamic analysis

KB-R7785, a new MMP inhibitor, reduces brain damage in focal cerebral ischemia

Glimepiride may be safer than conventional sulfonylureas in diabetics with coronary artery disease

Weston Medical regains European rights to Intraject; Abbott license agreement reported

Novel pharmacological effect described for tyrosine kinase inhibitor STI-571

Genzyme General continues to make good progress in advancing development programs

Merck completes acquisition of Rosetta

Salmosin gene therapy associated with antitumor and antimetastatic effects in mouse model

FDA approves changes in Copaxone labeling

Pfizer achieves important milestones during Q2 2001

Adenovirus-mediated CTLA4IgG gene therapy prevents development of arthritis

Texas Biotechnology receives approvable letter from FDA for expanded argatroban indication

Bisphosphonates recommended as first-line therapy for GIO

Pharmos provides update on key products

Red blood cell-mediated delivery of an antiviral prodrug useful against HIV and HSV

Inhibitors of Ras farnesylation and use in hyperproliferative diseases

Bradykinin antagonists, pharmaceutical compositions and methods of use

MethylGene designs histone deacetylase inhibitors useful for cancer, restenosis, psoriasis

Preparation and use of new potassium channel inhibitors described by BMS

Fujisawa claims new series of adenosine receptor antagonists

Research at U.S. university leads to new cell regulation modulators

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...